Company · Abingdon
Summit (Oxford) Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Summit (Oxford) Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 21
- Ankur Dhingra 2022-2024 View profile
- Campbell Hair 2021-2022 View profile
- Jeffrey Maranian 2021-2022 View profile
- Dr David Jonathan Powell 2021-2021 View profile
- Dr Ventzislav Kirilov Stefanov 2020-2020 View profile
- Glyn Owain Edwards 2012-2020 View profile
- Dr Barry John Price 2011-2012 View profile
- James Christopher Taylor 2006-2008 View profile
- Dr Richard Storer 2006-2012 View profile
- Darren Michael Millington 2005-2008 View profile
- Dr Steven Koon Ching Lee 2003-2010 View profile
- David Robert Norwood 2003-2008 View profile
- Professor Stephen Graham Davies 2003-2013 View profile
- Dr Andrew William Mulvaney 2003-2005 View profile
- Wcphd Directors Limited 2003-2003 View profile
- Hugh Feargal O'Neill 2020-2021 View profile
- Melissa Claire Strange 2016-2020 View profile
- Anthony Weir 2008-2009 View profile
- Sharon Jeen Benning Prince 2008-2008 View profile
- John Alexander Montgomery 2003-2006 View profile
- Wcphd Secretaries Limited 2003-2004 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 14/01/2003
- Registered office
- Abingdon
- Previous names
- Vastox Chemical Genomics Limited (until 06/08/2007)
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Summit Therapeutics Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06
Group
- Summit (Oxford) Limited
is controlled by Summit Therapeutics Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Summit Therapeutics Limited.
9 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- Robert William Duggan Director · appointed 2020
- Manmeet Singh Soni Director · appointed 2023
- Bhaskar Anand Director · appointed 2024
Directors past 6 years
- Robert William Duggan Director · appointed 2020
First-time vs portfolio directors
Portfolio (3)
- Robert William Duggan Director · appointed 2020
- Manmeet Singh Soni Director · appointed 2023
- Bhaskar Anand Director · appointed 2024
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 04636431
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 31/12/2026
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data